<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Experimental and Clinical Surgery</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Experimental and Clinical Surgery</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник экспериментальной и клинической хирургии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2070-478X</issn><issn publication-format="electronic">2409-143X</issn><publisher><publisher-name xml:lang="en">Voronezh State Medical University named after N.N. Burdenko</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">62</article-id><article-id pub-id-type="doi">10.18499/2070-478X-2012-5-2-247-252</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Unknown</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Correction of lipid-transport system at experimental widespread purulent peritonitis</article-title><trans-title-group xml:lang="ru"><trans-title>Коррекция изменений липид-транспортной системы при экспериментальном распространенном гнойном перитоните</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Гостищев</surname><given-names>В.К.</given-names></name><bio xml:lang="ru"><p>д.м.н., проф., академик РАМН, Президент Ассоциации общих хирургов Российской Федерации, зав. кафедрой общей хирургии Первого Московского государственного медицинского университета им. И.М.Сеченова, председатель проблемной комиссии «Инфекция в хирургии» Межведомственного научного Совета по хирургии РАМН и Министерства здравоохранения Российской Федерации.</p></bio><email>author@vestnik-surgery.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Косинец</surname><given-names>В.A.</given-names></name><bio xml:lang="ru"><p>к.м.н.,  док-торант кафедры общей хирургии Первого Москов-ского государственного медицинского университе-та им. и.М.сеченова; e-mail: vkosinets@yandex.by</p></bio><email>author@vestnik-surgery.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет им. И.М.Сеченова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2012-06-24" publication-format="electronic"><day>24</day><month>06</month><year>2012</year></pub-date><volume>5</volume><issue>2</issue><issue-title xml:lang="ru"/><fpage>247</fpage><lpage>252</lpage><history><date date-type="received" iso-8601-date="2016-04-26"><day>26</day><month>04</month><year>2016</year></date><date date-type="accepted" iso-8601-date="2016-04-26"><day>26</day><month>04</month><year>2016</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2012, ., .</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2012, Гостищев В., Косинец В.</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="en">., .</copyright-holder><copyright-holder xml:lang="ru">Гостищев В., Косинец В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnik-surgery.com/journal/article/view/62">https://vestnik-surgery.com/journal/article/view/62</self-uri><abstract xml:lang="en"><p>Research is spent on 40 rabbits-males of chinchilla breed. For the first time influence of a preparation of omega-3 fatty acids «Omegaven» on protein-lipid spectrum of blood is studied at an experimental widespread purulent peritonitis. It is established that in the postoperative period «Omegaven» effectively influences on protein-lipid spectrum of blood by prevention of sharp decrease in quantity of proteins, lipoproteins of high density (HDL) and maintenance of triglyceride’s growth. Positive action of the preparation also is connected with percentage decrease of lisophosphatides and level increase of polyglycerophosphatides in phopholipid spectrum of HDL.</p></abstract><trans-abstract xml:lang="ru"><p>Исследование проведено на 40 кроликах-самцах породы шиншилла. Впервые изучено влияние препарата омега-3 жирных кислот «Омегавен» на липидно-белковый спектр сыворотки крови при экспериментальном распространенном гнойном перитоните. Установлено, что в послеоперационном периоде «Омегавен» эффективно влияет на липидно-белковый спектр сыворотки крови путем предотвращения резкого снижения количества белка, липопротеинов высокой плотности (ЛПВП) и роста содержания триглицеридов. Положительное действие препарата также связано со снижением процентного содержания лизофосфатидов и увеличением уровня полиглицерофосфати- дов в фосфолипидном спектре ЛПВП.</p></trans-abstract><kwd-group xml:lang="en"><kwd>widespread purulent peritonitis</kwd><kwd>«Omegaven»</kwd><kwd>lipid-transport system</kwd><kwd>phospholipids</kwd><kwd>cholesterol</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>распространенный гнойный перитонит</kwd><kwd>«Омегавен»</kwd><kwd>липид-транспортная система</kwd><kwd>фосфолипиды</kwd><kwd>холестерол</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Gostishchev V.K., Sazhin V.P., Avdovenko A.L. Peritonit GEOTAR-Media M 2002; 238.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Eriukhin I.A., Shliapnikov S.A., Efimova I.S. Peritonit i abdominal'nyi sepsis [Peritonitis and abdominal sepsis]. Inf. v khir. 2004; 2: 2-7.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Efimenko, N.A. Rozanov V.E., Bolotnikov A.I. Immunopatogenez i kontseptsiia sovremennoi immunoterapii peritonita u postradavshikh s tiazheloi sochetannoi travmoi zhivota [Immunopatogenez and the concept of modern immunotherapy peritonitis in patients with severe concomitant injury of the abdomen] OOO «AVTOGRAF M 2008; 302.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Keits M. Tekhnika lipidologii [Equipment lipidology]. Mir M 1975; 76, 138-140, 310-311.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Osochuk S.S. Izmeneniia lipidtransportnoi sistemy pri eksperimental'nom peritonite u krys[Changes lipidtransport system in experimental peritonitis in rats]. Biulleten' eksperimental'noi biologii i meditsiny.2002; 8: 169-171.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Pokrovskii A.A. Biokhimicheskie metody issledovaniia [Biochemical methods of investigation] Meditsina. M 1969; 477.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Savel'ev B.C., Gel'fanda B.R., Filimonova M.I. Peritonit: praktich. rukov. [Peritonitis: A Practical Guide] Litterra M 2006; 208.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Khanevich, M.D., Selivanov E.A., Starokon' P.M. Peritonit: Infuzionno-transfuzionnaia i detoksikatsionnaia terapiia [Peritonitis: infusion-transfusion therapy and detox] MedEkspertPress M 2004; 205.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Zingerenko V.B. Effektivnost' gliutamina v korrektsii metabolicheskikh narushenii u bol'nykh peritonitom [The effectiveness of glutamine in the correction of metabolic disorders in patients with peritonitis]. Inf. v khir. M 2008; 1: 45-50.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Iupatov, G.I. Immunnaia i lipidtransportnaia sistemy: kliniko metabolicheskie aspekty [The immune and lipid transport system: clinical and metabolic aspects]: avtoref. dis. ... d-ra med. nauk Vitebsk 2003; 41.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Laurila A. et al.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Associacija helikobakternoj infekcii s povyshennym urovnem lipidov v syvorotke krovi. Ateroskleroz [Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis]. 1999; 142: 207–210.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Auerbach, B.J., Parks J.S Lipoproteinov otklonenija, svjazannye s lipopolisaharida inducirovannoj lecitina: holesterin aciltransferazy i deficit lipazy [Lipoprotein abnormalities associated with lipopolysaccharide-induced lecithin: cholesterol acyltransferase and lipase deficiency] J. Biol. Chem. 1989;. 264: 10264-10270.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Byrne, C.D. Bogatykh triglitseridami lipoproteinov: sviaz' s aterosklerozom oposredovannaia provospalitel'nykh i prokoaguliantnoi fenotipa? [Triglyceride-rich lipoproteins: are links with atherosclerosis mediated by a procoagulant and proinflammatory phenotype?] Atherosclerosis. 1999; 145: 1-15.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Festa A. et al.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Khronicheskoe subklinicheskoe vospalenie kak chast' sindroma rezistentnosti k insulinu [Chronic subclinical inflammation as a part of the insulin resistance sindrome]. The Insulin Resistance Atherosclerosis Study (IRAS) Circulation. 2000; 102; 42-47.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Harris H.W. et al. Chylomicrons izmenit' sud'bu endotoksina, umen'shaia vysvobozhdenie faktora nekroza opukholi i predotvrashcheniia smerti J. Clin [Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death J. Clin]. Invest. 1993; 91: 1028-1034.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Clarissa M., Whitehead Alexander Uhlar. Syvorotochnyi amiloid A, glavnym pozvonochnoe ostroi fazy reagentov [Serum amyloid A, the major vertebrate acute-phase reac-tant] Eur. J. Biochem. 1999; 265: 501-523.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>D. Sander et al.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Rasshirennyi progressirovanie rannego ateroskleroza sonnykh arterii sviazano s khlamidiinoi pnevmonii (Taivan' ostryi respiratornyi) seropozitivnost'iu [Edvanced progression of early carotid atherosclerosis is related to Chlamidia pneumoniae (Taiwan acute respiratory) seropositivity] Circulation. 2001; 103: 1390–1395.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Gallin, J.I., Kaye D., O'Leary W.M Syvorotochnye lipidy infektsii [Serum lipids in infection]. N. Engl. J. Med. 1969; 281: 1081–1086.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Woods A. et al. Genetika vospaleniia i riskom razvitiia ishemicheskoi bolezni serdtsa: tsentral'naia rol' interleikina-6 [Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6]Europ. Heart. J. 2000; 21: 1574-1583.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Gornall, A.C., Bardawill C.J., David M.M</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Opredelenie syvorotochnykh belkov s pomoshch'iu reaktsii biureta [Determination of serum proteins by means of the biuret reaction] J. Biol. Chem. 1949;. 177: 751-766.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Chiarla C. et al. Giperkholesterinemiia v kriticheskoi bolezni [Hypocholesterolemia in critical illness] Critical Care Medicine. 2009; 37: 2681-2682.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Bonnefoy M et al Giperkholesterinemii u gospitalizirovannykh pozhilykh: otnosheniia s vospalitel'nym i pitatel'nogo statusa [Hypocholesterolemia in hospitalized elderly: relations with inflammatory and nutritional status] Rev. Med. Interne. 2002; 23: 991-998.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Khovidhunkit Weerapan et al. Infektsiei i vospalenie Indutsirovannye proaterogennymi Izmeneniiami lipoproteinov</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>[Infection and InflammationInduced Proatherogenic Changes of Lipoproteins] The Journal of Infectious Diseases. 2000; 181: 462-472.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Kruger, P.S.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Zabud'te gliukozu: chto o lipidakh v kriticheskoi bolezni? [Forget glucose: what about lipids in critical illness?] Crit. Care Resusc. 2009; 11: 305-309.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Hardardóttir I. et al LPS i tsitokiny reguliruiut dopolnitel'nye pechenochnye urovni mRNK apolipoproteinov vo vremia otvetnoi reaktsii ostroi fazy v siriiskikh khomiakov [LPS and cytokines regulate extra hepatic mRNA levels of apolipoproteins during the acute phase response in Syrian hamsters] Biochim. Biophys. Acta. 1997; 1344: 210-220.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Mayer K. et al. Parenteral'noe pitanie s ryb'im zhirom modulirovat' tsitokinovogo otveta u patsientov s sepsisom [Parenteral nutrition with fish oil modulate cytokine response in patients with sepsis] Am. R. Respir. Crit. Care. Med. 2003; 167; 1321-1328.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Salazar, A., Pinto X, Mana J.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Syvorotochnye markery vospaleniia pri sarkoidoze i drugie sistemnye rasstroistva: syvorotochnyi amiloid A i kholesterina lipoproteinov vysokoi plotnosti [Serum amyloid A and highdensity lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders] Eur. J. Clin. Invest. 2001; 31: 1070-1077.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Bonville D.A. et al. Otnosheniia giperkholesterinemii k kontsentratsii tsitokinov i smertnosti bol'nykh v kriticheskom sostoianii s sindromom sistemnoi vospalitel'noi reaktsii [The relationships of hypocholesterolemia to cytokine concentrations and mortality in critically ill patients with systemic inflammatory response syndrome] Surg. Infect. (Larchmt). 2004; 5: 39-49.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Valentine, R.C., Valentine D.L</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Omega-3 zhirnye kisloty v kletochnykh membranakh: odno poniatie [Omega-3 fatty acids in cellular membranes: a unified concept] Prog. Lipid. Res. 2004; 43: 383-402.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Vaskovsky, V.E., Kostetsky E.J.,. Vassenolin J.M A universal reagent for phospholipid analysis J. Chromatogr. 1975;. 114: 129-141.</mixed-citation></ref></ref-list></back></article>
